In a groundbreaking development, researchers have discovered a potential solution to the pervasive issue of "forever chemicals" in our bloodstreams. This innovative approach, utilizing a specialized machine, offers a glimmer of hope in the ongoing battle against these persistent pollutants.
The machine, a well-established tool in the medical field, has been modified to not only remove cholesterol but also target and extract forever chemicals. This is a significant advancement, considering that nearly every person on the planet carries these harmful substances, with no practical means of elimination until now.
Understanding Forever Chemicals
Forever chemicals, or PFAS (per- and polyfluoroalkyl substances), are a group of over 4,700 compounds that are incredibly persistent in the environment. Biomonitoring studies have detected these chemicals in the blood of over 99% of Americans, with exposure primarily occurring through contaminated drinking water. The persistence of these compounds is alarming, as it takes nearly a decade for their levels to drop by half, meaning a person's exposure at a young age can have long-lasting effects.
Additionally, plastic particles, which we inadvertently consume and inhale, have also been found in various human tissues, including blood, placenta, and even the brain. What connects these two types of pollutants is their affinity for fat.
The Role of Fat in Pollutant Transport
PFAS compounds settle onto LDL and VLDL particles, which are responsible for transporting cholesterol throughout the body. Similarly, plastic particles also adhere to these fats, with weathered plastic being particularly effective at attracting these pollutants. This raises an interesting question: Could the fats that carry these pollutants also be the key to their removal?
The Potential of Blood Treatment
The research team, based at the world's largest apheresis center, has developed a hypothesis that both PFAS and plastic particles pick up a coat of plasma fats, allowing them to circulate in the bloodstream. Their innovative approach involves using a filter designed to strip these fats, which, in turn, could drag out the pollutants as well.
Initial results from the study are promising. In a small sample of patients, the treatment led to significant reductions in several common forever chemicals, as measured by mass spectrometry. Additionally, these pollutants were found in the discarded fluid, further supporting the idea that they were successfully removed from the bloodstream.
Microplastic Evidence and Skin Samples
While the evidence for microplastic removal is less conclusive, the research team has developed a method to locate and identify plastic particles in human tissue using Raman spectroscopy. This capability is a significant advancement, as it allows for a more precise understanding of the distribution and impact of these particles in the body.
Furthermore, experiments exposing human adrenal cells to polystyrene beads suggest a potential link between plastic particles and cell death. While the results are preliminary, they highlight the need for further investigation into the long-term effects of plastic exposure.
Safety and Limitations
The apheresis treatment has a long history of safe use, with over 200 sessions conducted weekly at the Dresden program. According to Dr. Bornstein, the lead author of the study, the treatment has been highly effective in managing inherited high cholesterol, with a significant reduction in cardiovascular events among patients.
However, the study does have limitations. The sample size is small, and the conditions of the patients and the types of machines used varied. Additionally, the methods used to detect plastic particles are still exploratory, and the potential for contamination in the laboratory environment is a concern.
The most critical limitation is the short-term nature of the study. The reductions observed reflect an acute change in circulating pollutants immediately after the procedure and do not account for the total load stored in the body. Further research is needed to understand the long-term effects and the body's response to the removal of these pollutants.
Future Research and Implications
The research team plans to conduct larger follow-up studies to validate their findings and explore the potential of this treatment for patients with cardiometabolic and neurometabolic diseases. The Advanced Research Projects Agency for Health has also taken notice, launching a $144 million program to develop methods for removing plastic particles from the body.
While this research offers a promising avenue for addressing the issue of forever chemicals and plastic pollution in our bodies, Dr. Bornstein emphasizes that prevention remains the first priority. Cleaning up after exposure is a more challenging and costly approach, highlighting the importance of addressing the root causes of pollution.
This research opens up a new frontier in the fight against environmental pollutants, offering a glimmer of hope for a healthier future.
